Annual CFF
$15.28 M
-$4.04 M-20.90%
31 December 2023
Summary:
Achieve Life Sciences annual cash flow from financing activities is currently $15.28 million, with the most recent change of -$4.04 million (-20.90%) on 31 December 2023. During the last 3 years, it has fallen by -$17.40 million (-53.25%). ACHV annual CFF is now -71.83% below its all-time high of $54.24 million, reached on 31 December 2012.ACHV Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$8.11 M
-$7.96 M-5201.96%
30 September 2024
Summary:
Achieve Life Sciences quarterly cash flow from financing activities is currently -$8.11 million, with the most recent change of -$7.96 million (-5201.96%) on 30 September 2024. Over the past year, it has dropped by -$8.11 million (-100.00%). ACHV quarterly CFF is now -114.46% below its all-time high of $56.11 million, reached on 31 March 2024.ACHV Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$47.84 M
-$8.11 M-14.50%
30 September 2024
Summary:
Achieve Life Sciences TTM cash flow from financing activities is currently $47.84 million, with the most recent change of -$8.11 million (-14.50%) on 30 September 2024. Over the past year, it has increased by +$14.85 million (+45.02%). ACHV TTM CFF is now -32.93% below its all-time high of $71.34 million, reached on 31 March 2024.ACHV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACHV Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.9% | -100.0% | +45.0% |
| 3 y3 years | -53.3% | -10000.0% | +27.2% |
| 5 y5 years | -22.7% | -100.0% | +396.7% |
ACHV Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -58.3% | at low | -114.5% | at low | -32.9% | +213.2% |
| 5 y | 5 years | -58.3% | at low | -114.5% | at low | -32.9% | +396.7% |
| alltime | all time | -71.8% | >+9999.0% | -114.5% | at low | -32.9% | +9130.8% |
Achieve Life Sciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.11 M(+5202.0%) | $47.84 M(-14.5%) |
| June 2024 | - | -$153.00 K(-100.3%) | $55.96 M(-21.6%) |
| Mar 2024 | - | $56.11 M(>+9900.0%) | $71.34 M(+367.0%) |
| Dec 2023 | $15.28 M(-20.9%) | $0.00(0.0%) | $15.28 M(-53.7%) |
| Sept 2023 | - | $0.00(-100.0%) | $32.99 M(-0.4%) |
| June 2023 | - | $15.23 M(>+9900.0%) | $33.12 M(+71.9%) |
| Mar 2023 | - | $47.00 K(-99.7%) | $19.27 M(-0.2%) |
| Dec 2022 | $19.32 M(-47.2%) | $17.71 M(>+9900.0%) | $19.32 M(+16.8%) |
| Sept 2022 | - | $126.00 K(-90.9%) | $16.53 M(+0.7%) |
| June 2022 | - | $1.38 M(+1353.7%) | $16.41 M(-55.0%) |
| Mar 2022 | - | $95.00 K(-99.4%) | $36.47 M(-0.4%) |
| Dec 2021 | $36.61 M(+12.0%) | $14.93 M(>+9900.0%) | $36.61 M(-2.7%) |
| Sept 2021 | - | $8000.00(-100.0%) | $37.62 M(-28.0%) |
| June 2021 | - | $21.44 M(+8983.9%) | $52.23 M(+58.5%) |
| Mar 2021 | - | $236.00 K(-98.5%) | $32.96 M(+0.9%) |
| Dec 2020 | $32.68 M(+88.6%) | $15.94 M(+9.0%) | $32.68 M(+11.0%) |
| Sept 2020 | - | $14.62 M(+574.7%) | $29.44 M(+98.6%) |
| June 2020 | - | $2.17 M(-4710.6%) | $14.82 M(-14.2%) |
| Mar 2020 | - | -$47.00 K(-100.4%) | $17.28 M(-0.3%) |
| Dec 2019 | $17.32 M(-12.3%) | $12.70 M(>+9900.0%) | $17.32 M(+79.9%) |
| Sept 2019 | - | $0.00(-100.0%) | $9.63 M(-8.1%) |
| June 2019 | - | $4.62 M(>+9900.0%) | $10.48 M(-43.8%) |
| Mar 2019 | - | $0.00(-100.0%) | $18.65 M(-5.6%) |
| Dec 2018 | $19.76 M(+887.4%) | $5.01 M(+492.2%) | $19.76 M(+26.3%) |
| Sept 2018 | - | $846.00 K(-93.4%) | $15.64 M(-1.5%) |
| June 2018 | - | $12.80 M(+1058.0%) | $15.88 M(+414.6%) |
| Mar 2018 | - | $1.10 M(+23.6%) | $3.09 M(+54.2%) |
| Dec 2017 | $2.00 M(+1234.0%) | $894.00 K(-17.8%) | $2.00 M(+59.2%) |
| Sept 2017 | - | $1.09 M(>+9900.0%) | $1.26 M(+639.4%) |
| June 2017 | - | $0.00(-100.0%) | $170.00 K(0.0%) |
| Mar 2017 | - | $20.00 K(-86.7%) | $170.00 K(+13.3%) |
| Dec 2016 | $150.00 K(-99.1%) | $150.00 K(>+9900.0%) | $150.00 K(+971.4%) |
| Sept 2016 | - | $0.00(0.0%) | $14.00 K(-99.9%) |
| June 2016 | - | $0.00(0.0%) | $14.43 M(-18.2%) |
| Mar 2016 | - | $0.00(-100.0%) | $17.64 M(+0.3%) |
| Dec 2015 | $17.59 M(-30.3%) | $14.00 K(-99.9%) | $17.59 M(+0.0%) |
| Sept 2015 | - | $14.42 M(+348.7%) | $17.59 M(-21.3%) |
| June 2015 | - | $3.21 M(-6278.8%) | $22.34 M(-11.2%) |
| Mar 2015 | - | -$52.00 K(-500.0%) | $25.16 M(-0.3%) |
| Dec 2014 | $25.25 M(>+9900.0%) | $13.00 K(-99.9%) | $25.25 M(+0.1%) |
| Sept 2014 | - | $19.17 M(+217.7%) | $25.23 M(+316.1%) |
| June 2014 | - | $6.03 M(>+9900.0%) | $6.06 M(>+9900.0%) |
| Mar 2014 | - | $30.00 K(>+9900.0%) | $30.00 K(+200.0%) |
| Dec 2013 | $10.00 K(-100.0%) | $0.00(0.0%) | $10.00 K(-16.7%) |
| Sept 2013 | - | $0.00(0.0%) | $12.00 K(-96.6%) |
| June 2013 | - | $0.00(-100.0%) | $358.00 K(-23.8%) |
| Mar 2013 | - | $10.00 K(+400.0%) | $470.00 K(-99.1%) |
| Dec 2012 | $54.24 M(>+9900.0%) | $2000.00(-99.4%) | $54.24 M(-0.0%) |
| Sept 2012 | - | $346.00 K(+208.9%) | $54.24 M(+0.4%) |
| June 2012 | - | $112.00 K(-99.8%) | $54.02 M(+0.2%) |
| Mar 2012 | - | $53.78 M(>+9900.0%) | $53.91 M(>+9900.0%) |
| Dec 2011 | $219.00 K(-99.5%) | $6000.00(-95.1%) | $219.00 K(-99.5%) |
| Sept 2011 | - | $122.00 K(>+9900.0%) | $47.02 M(-0.1%) |
| June 2011 | - | $0.00(-100.0%) | $47.05 M(-0.7%) |
| Mar 2011 | - | $91.00 K(-99.8%) | $47.39 M(-0.2%) |
| Dec 2010 | $47.48 M | $46.81 M(>+9900.0%) | $47.48 M(+448.8%) |
| Sept 2010 | - | $153.00 K(-54.5%) | $8.65 M(-51.5%) |
| June 2010 | - | $336.00 K(+81.6%) | $17.84 M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $185.00 K(-97.7%) | $17.51 M(+0.9%) |
| Dec 2009 | $17.35 M(>+9900.0%) | $7.98 M(-14.6%) | $17.35 M(+82.8%) |
| Sept 2009 | - | $9.34 M(>+9900.0%) | $9.49 M(+6667.5%) |
| June 2009 | - | $9000.00(-60.9%) | $140.20 K(+1.1%) |
| Mar 2009 | - | $23.00 K(-80.5%) | $138.70 K(+14.6%) |
| Dec 2008 | $121.00 K(-51.2%) | $118.00 K(-1304.1%) | $121.00 K(+268.9%) |
| Sept 2008 | - | -$9800.00(-230.7%) | $32.80 K(-67.7%) |
| June 2008 | - | $7500.00(+41.5%) | $101.70 K(-56.2%) |
| Mar 2008 | - | $5300.00(-82.2%) | $232.30 K(-6.4%) |
| Dec 2007 | $248.00 K(-99.1%) | $29.80 K(-49.6%) | $248.10 K(-38.6%) |
| Sept 2007 | - | $59.10 K(-57.2%) | $404.10 K(+7.6%) |
| June 2007 | - | $138.10 K(+554.5%) | $375.60 K(-98.7%) |
| Mar 2007 | - | $21.10 K(-88.6%) | $28.85 M(-1.0%) |
| Dec 2006 | $29.14 M(-21.6%) | $185.80 K(+507.2%) | $29.14 M(-39.9%) |
| Sept 2006 | - | $30.60 K(-99.9%) | $48.47 M(-26.6%) |
| June 2006 | - | $28.61 M(+9147.2%) | $66.03 M(+76.2%) |
| Mar 2006 | - | $309.40 K(-98.4%) | $37.48 M(+0.9%) |
| Dec 2005 | $37.16 M(+132.8%) | $19.52 M(+11.0%) | $37.16 M(+110.9%) |
| Sept 2005 | - | $17.58 M(>+9900.0%) | $17.62 M(>+9900.0%) |
| June 2005 | - | $66.00 K(-867.4%) | $94.20 K(-99.4%) |
| Mar 2005 | - | -$8600.00(-39.9%) | $15.06 M(-5.7%) |
| Dec 2004 | $15.97 M(+14.6%) | -$14.30 K(-128.0%) | $15.97 M(-4.5%) |
| Sept 2004 | - | $51.10 K(-99.7%) | $16.71 M(-44.1%) |
| June 2004 | - | $15.03 M(+1574.6%) | $29.87 M(+101.6%) |
| Mar 2004 | - | $897.60 K(+22.9%) | $14.82 M(+6.3%) |
| Dec 2003 | $13.94 M(+9.3%) | $730.50 K(-94.5%) | $13.94 M(+8.6%) |
| Sept 2003 | - | $13.21 M(<-9900.0%) | $12.83 M(-4582.1%) |
| June 2003 | - | -$23.40 K(-228.6%) | -$286.20 K(+4108.8%) |
| Mar 2003 | - | $18.20 K(-104.8%) | -$6800.00(-100.1%) |
| Dec 2002 | $12.75 M(+130.8%) | -$378.60 K(-487.9%) | $12.75 M(-32.2%) |
| Sept 2002 | - | $97.60 K(-61.9%) | $18.81 M(-1.5%) |
| June 2002 | - | $256.00 K(-98.0%) | $19.09 M(+4.4%) |
| Mar 2002 | - | $12.78 M(+125.1%) | $18.28 M(+230.9%) |
| Dec 2001 | $5.52 M(+845.2%) | $5.68 M(+1368.4%) | $5.52 M(-3773.2%) |
| Sept 2001 | - | $386.50 K(-169.5%) | -$150.40 K(-71.6%) |
| June 2001 | - | -$556.50 K(-3028.9%) | -$529.80 K(-1715.2%) |
| Mar 2001 | - | $19.00 K(+3066.7%) | $32.80 K(-94.4%) |
| Dec 2000 | $584.50 K(-6742.0%) | $600.00(-91.5%) | $584.50 K(+3.5%) |
| Sept 2000 | - | $7100.00(+16.4%) | $564.80 K(-0.6%) |
| June 2000 | - | $6100.00(-98.9%) | $568.00 K(+23.0%) |
| Mar 2000 | - | $570.70 K(-3088.0%) | $461.90 K(-5348.9%) |
| Dec 1999 | -$8800.00(-100.7%) | -$19.10 K(-285.4%) | -$8800.00(-155.0%) |
| Sept 1999 | - | $10.30 K(-110.3%) | $16.00 K(-84.9%) |
| June 1999 | - | -$100.00 K(-200.0%) | $105.70 K(-86.9%) |
| Mar 1999 | - | $100.00 K(+1654.4%) | $805.70 K(-33.2%) |
| Dec 1998 | $1.21 M(+0.5%) | $5700.00(-94.3%) | $1.21 M(-45.2%) |
| Sept 1998 | - | $100.00 K(-83.3%) | $2.20 M(0.0%) |
| June 1998 | - | $600.00 K(+20.0%) | $2.20 M(+29.4%) |
| Mar 1998 | - | $500.00 K(-50.0%) | $1.70 M(+41.7%) |
| Dec 1997 | $1.20 M(-70.0%) | $1.00 M(+900.0%) | $1.20 M(+500.0%) |
| Sept 1997 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| June 1997 | - | $100.00 K(>+9900.0%) | $100.00 K(-97.5%) |
| Mar 1997 | - | $0.00(0.0%) | $4.00 M(0.0%) |
| Dec 1996 | $4.00 M(-83.7%) | $0.00(0.0%) | $4.00 M(0.0%) |
| Sept 1996 | - | $0.00(-100.0%) | $4.00 M(0.0%) |
| June 1996 | - | $4.00 M(>+9900.0%) | $4.00 M(>+9900.0%) |
| Mar 1996 | - | $0.00 | $0.00 |
| Dec 1995 | $24.60 M(+602.9%) | - | - |
| Dec 1994 | $3.50 M | - | - |
FAQ
- What is Achieve Life Sciences annual cash flow from financing activities?
- What is the all time high annual CFF for Achieve Life Sciences?
- What is Achieve Life Sciences annual CFF year-on-year change?
- What is Achieve Life Sciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Achieve Life Sciences?
- What is Achieve Life Sciences quarterly CFF year-on-year change?
- What is Achieve Life Sciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Achieve Life Sciences?
- What is Achieve Life Sciences TTM CFF year-on-year change?
What is Achieve Life Sciences annual cash flow from financing activities?
The current annual CFF of ACHV is $15.28 M
What is the all time high annual CFF for Achieve Life Sciences?
Achieve Life Sciences all-time high annual cash flow from financing activities is $54.24 M
What is Achieve Life Sciences annual CFF year-on-year change?
Over the past year, ACHV annual cash flow from financing activities has changed by -$4.04 M (-20.90%)
What is Achieve Life Sciences quarterly cash flow from financing activities?
The current quarterly CFF of ACHV is -$8.11 M
What is the all time high quarterly CFF for Achieve Life Sciences?
Achieve Life Sciences all-time high quarterly cash flow from financing activities is $56.11 M
What is Achieve Life Sciences quarterly CFF year-on-year change?
Over the past year, ACHV quarterly cash flow from financing activities has changed by -$8.11 M (-100.00%)
What is Achieve Life Sciences TTM cash flow from financing activities?
The current TTM CFF of ACHV is $47.84 M
What is the all time high TTM CFF for Achieve Life Sciences?
Achieve Life Sciences all-time high TTM cash flow from financing activities is $71.34 M
What is Achieve Life Sciences TTM CFF year-on-year change?
Over the past year, ACHV TTM cash flow from financing activities has changed by +$14.85 M (+45.02%)